TrialValue® reference material
Study archetypes, budget ranges, payment models, participant burden and value measures.
Open →Life sciences · patient access · organisational learning
Knowledge, decisions and value.
Trial execution keeps getting more sophisticated — systems, automation, operational discipline. The decisions that shape it often haven't kept pace: budgets, incentives and governance still lean on fragmented information and individual judgement, so the cost shows up late, as amendments, renegotiation and participant burden discovered after the fact. RHIEOS works alongside organisations with practice-informed advisory, tools and platform access, so they can learn better, decide well and create value.
How we think about a decision
One loop behind four areas.
A decision has a context, needs a real choice, gets made with judgement, earns trust rather than assuming it, and produces something worth learning from next time. That's the same loop whether the context is a trial budget, a GxP process, or a workforce decision. Access, Assurance, Asset Value and Learning are where it shows up, not four separate businesses.
What we work on
Four areas, one loop.
Different questions need different evidence and methods. Each one connects back to the same decision loop above.
Access
Access begins before approval.
Reducing trial financial burden, then broader patient and health-system access, including HEMA-Global™.
Explore Access → AssuranceTrust the process, not just the tool.
Decision rights, oversight and partnering across regulated work, including AI-supported GxP.
Explore Assurance → Asset ValueUse evidence before assumptions harden.
Partners, budgets, contracts and the scientific knowledge clinical development creates.
Explore Asset Value → LearningMake learning part of how the organisation works.
Purpose, goals, judgement, outcomes and capability, without another reporting layer.
Explore Learning →Open Resources
Read. View. Use.
Public summaries, reference material, models and working artefacts. No form or sign-in — free to use under CC BY 4.0, unless a resource says otherwise.
Knowledge ePV™
Reframing clinical development as an investment in scientific knowledge.
Open →AI Assurance for GxP™
Human oversight, evidence, capability, change and recovery.
Open →Enterprise Decision Compass™
Purpose, goals, judgement, outcomes, capability and learning.
Open →Notes & Exchange
Short working notes, questions, corrections and responses linked to the resources.
How to work with RHIEOS
Five ways in.
Different needs call for a different mode of engagement — from a single working session to tools running inside your own systems.
Advisory session
A live working session, in person or online, structured around one decision — ending in a written report.
Decision Intelligence platform
RHIEOS Decision Intelligence delivered via API, for teams who want the logic inside their own systems.
Customisation & deployment
Configuring and embedding RHIEOS tools and models inside an organisation's existing workflow.
Tools, under support
Ongoing access to TrialValue®, Dealligence® and CTAide™, with support included.
Open Resources
Public papers, models and reference material — free to read, download and use, no engagement required.
We work with life-science organisations, service partners, patient groups and specialists across clinical development, safety, quality, finance, outsourcing, legal, access, data/AI and leadership.
Who we work with →About RHIEOS
Built from practice across life sciences.
RHIEOS Ventures was founded in 2013 by Larry Ajuwon, Managing Partner, who leads the practice together with a network of independent partners and specialists brought in by area of work.
About RHIEOS →Want to discuss application, collaboration or a RHIEOS resource?
— Larry Ajuwon, Managing Partner